Published in JAMA on July 09, 1997
Acamprosate to Reduce Symptoms of Alcohol Withdrawal | NCT00106106
Delirium: optimising management. BMJ (2001) 2.31
Alcohol's effects on sleep in alcoholics. Alcohol Res Health (2001) 2.04
Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol (2010) 1.93
Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcohol Clin Exp Res (2012) 1.66
The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med (2002) 1.63
Pharmacologic treatment of alcohol withdrawal. JAMA (1997) 1.60
Ethanol in formularies of US teaching hospitals. JAMA (2003) 1.44
Neurosteroids, GABAA receptors, and ethanol dependence. Psychopharmacology (Berl) (2005) 1.18
Delirium in the ICU: an overview. Ann Intensive Care (2012) 1.11
Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07
Who needs inpatient detox? Development and implementation of a hospitalist protocol for the evaluation of patients for alcohol detoxification. J Gen Intern Med (2014) 1.05
Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Psychopharmacology (Berl) (2003) 0.97
Diagnosis and management of acute alcohol withdrawal. CMAJ (1999) 0.96
Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat. Alcohol Clin Exp Res (2011) 0.96
Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ (1999) 0.95
Addressing alcohol addiction: lessons from a hospital based audit. Indian J Med Res (2013) 0.95
Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care (2012) 0.94
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res (2009) 0.94
Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr (2005) 0.93
Enhancement of the hypothalamic-pituitary-adrenal axis but not cytokine responses to stress challenges imposed during withdrawal from acute alcohol exposure in Sprague-Dawley rats. Psychopharmacology (Berl) (2011) 0.93
Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome. Indian J Pharmacol (2014) 0.90
Improving alcohol withdrawal outcomes in acute care. Perm J (2014) 0.89
GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci (2014) 0.88
Alcohol and opiate withdrawal in US jails. Am J Public Health (2004) 0.88
The association between the SLC6A3 VNTR 9-repeat allele and alcoholism-a meta-analysis. Alcohol Clin Exp Res (2011) 0.87
Prevalence and correlates of withdrawal-related insomnia among adults with alcohol dependence: results from a national survey. Am J Addict (2010) 0.86
Evaluation of an alcohol withdrawal protocol and a preprinted order set at a tertiary care hospital. Can J Hosp Pharm (2011) 0.83
The effectiveness of anticonvulsants in psychiatric disorders. Dialogues Clin Neurosci (2008) 0.82
Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures. Psychopharmacology (Berl) (2004) 0.82
Drug use for non-hepatic associated conditions in patients with liver cirrhosis. Eur J Clin Pharmacol (2003) 0.81
Acamprosate attenuates the handling induced convulsions during alcohol withdrawal in Swiss Webster mice. Physiol Behav (2008) 0.81
Identification and management of alcohol withdrawal syndrome. Drugs (2015) 0.81
Substance Use Disorders and Neurologic Illness. Curr Treat Options Neurol (2004) 0.80
Alcohol and the nervous system. J Neurol Neurosurg Psychiatry (2004) 0.80
A randomized trial of two behavioral interventions to improve outcomes following inpatient detoxification for alcohol dependence. J Addict Dis (2011) 0.80
The role of magnesium in the emergency department. Emerg Med J (2002) 0.80
Cognitive control network function in alcohol use disorder before and during treatment with lorazepam. Subst Use Misuse (2014) 0.80
Post-operative delirium after hip fracture treatment - a review of the current literature. Psychosoc Med (2006) 0.79
Therapeutic options and challenges for substances of abuse. Dialogues Clin Neurosci (2007) 0.79
Prescription Sedative Misuse and Abuse. Yale J Biol Med (2015) 0.78
A seizure attributed to ofloxacine in a woman undergoing detoxification for alcohol dependence. Case Rep Med (2010) 0.78
Binge ethanol withdrawal: Effects on post-withdrawal ethanol intake, glutamate-glutamine cycle and monoamine tissue content in P rat model. Behav Brain Res (2016) 0.78
Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res (2011) 0.78
Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions. Hosp Pharm (2015) 0.77
Treatment of alcohol withdrawal syndrome with a combination of tiapride/carbamazepine: results of a pooled analysis in 540 patients. Eur Arch Psychiatry Clin Neurosci (2006) 0.77
Diagnostic challenges in alcohol use disorder and alcoholic liver disease. World J Gastroenterol (2014) 0.77
[The alcoholic patient in the daily routine]. Wien Klin Wochenschr (2003) 0.77
Pharmacotherapy for alcohol use disorder: current and emerging therapies. Harv Rev Psychiatry (2015) 0.76
Care for hospitalized patients with unhealthy alcohol use: a narrative review. Addict Sci Clin Pract (2013) 0.76
Alcohol withdrawal kindling: is there a role for anticonvulsants? Psychiatry (Edgmont) (2005) 0.76
Alcohol withdrawal in the setting of elevated blood alcohol levels. Prim Care Companion J Clin Psychiatry (2006) 0.75
Ethical and legal aspects of conducting clinical trials in alcohol withdrawal syndrome. J Clin Diagn Res (2014) 0.75
Antidopaminergic drugs and acute pancreatitis: a population-based study. BMJ Open (2012) 0.75
Pharmacotherapy for Substance Use Disorders in Youths. J Child Adolesc Subst Abuse (2016) 0.75
Pharmacologic treatment of alcohol withdrawal. JAMA (1997) 0.75
The role of a medical toxicologist for assistance in the treatment of alcohol withdrawal syndrome. J Med Toxicol (2012) 0.75
Meta-Analysis of Effect Sizes Reported at Multiple Time Points Using General Linear Mixed Model. PLoS One (2016) 0.75
Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond. J Clin Diagn Res (2015) 0.75
Clinical pharmacology of old age syndromes. Br J Clin Pharmacol (2003) 0.75
Pharmacologic treatment of alcohol withdrawal. JAMA (1997) 0.75
The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders. Child Adolesc Psychiatr Clin N Am (2016) 0.75
Use of alcoholic beverages in VA medical centers. Subst Abuse Treat Prev Policy (2006) 0.75
Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats. Psychopharmacology (Berl) (2017) 0.75
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA (1999) 8.97
Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA (1994) 2.83
Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med (1996) 2.36
Alcohol withdrawal: a nationwide survey of inpatient treatment practices. J Gen Intern Med (1995) 1.52
Resident report: a conference with many uses. R I Med J (1990) 0.96
Impact of age on the severity, course, and complications of alcohol withdrawal. Arch Intern Med (1997) 0.83
Treatment of crack-cocaine-induced compulsive behavior with trazodone. J Subst Abuse Treat (1995) 0.79